{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:54:34Z","timestamp":1791078874370,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,2,1]],"date-time":"2001-02-01T00:00:00Z","timestamp":980985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2001,2]]},"DOI":"10.1067\/mjd.2001.110645","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T00:18:43Z","timestamp":1027556323000},"page":"253-260","source":"Crossref","is-referenced-by-count":52,"special_numbering":"P1","title":["Treatment of stage II cutaneous T-cell lymphoma with interferon alfa-2a and extracorporeal photochemotherapy: A prospective controlled trial"],"prefix":"10.1067","volume":"44","author":[{"given":"Uwe","family":"Wollina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Looks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhard","family":"Knopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Jrgen","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Liebold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta-Christina","family":"Hipler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mjd.2001.110645_bib1","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1182\/blood.V88.7.2385.bloodjournal8872385","article-title":"Mycosis fungoides and S?zary syndrome","volume":"88","author":"Diamandidou","year":"1996","journal-title":"Blood"},{"key":"10.1067\/mjd.2001.110645_bib2","first-page":"725","article-title":"Report of the committee on staging and classification of cutaneous T-cell lymphoma","volume":"63","author":"Bunn","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"10.1067\/mjd.2001.110645_bib3","doi-asserted-by":"crossref","first-page":"372","DOI":"10.7326\/0003-4819-109-5-372","article-title":"Histopathologic staging at initial diagnosis of mycosis fungoides and the S?zary syndrome: definition of three distinctive prognostic groups","volume":"109","author":"Sausville","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1067\/mjd.2001.110645_bib4","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1001\/archderm.1996.03890350051009","article-title":"Clinical stage IA (limited patch and plaque) mycosis fungoides: a long-term outcome analysis","volume":"132","author":"Kim","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2001.110645_bib5","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(96)91350-1","article-title":"Cutaneous T-cell lymphoma (mycosis fungoides)","volume":"347","author":"Lorincz","year":"1996","journal-title":"Lancet"},{"key":"10.1067\/mjd.2001.110645_bib6","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1056\/NEJM198912283212603","article-title":"A randomized trial comparing combination electronbeam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides","volume":"321","author":"Kaye","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2001.110645_bib7","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3109\/10428199809057618","article-title":"Systemic polychemotherapy in the treatment of primary cutaneous lymphomas: a clinical follow-up study of 81 patients treated with COP or CHOP","volume":"31","author":"Fierro","year":"1998","journal-title":"Leuk Lymphoma"},{"key":"10.1067\/mjd.2001.110645_bib8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000218803","article-title":"A rational approach to the therapy of cutaneous T-cell lymphomas","volume":"19","author":"Dummer","year":"1996","journal-title":"Onkologie"},{"key":"10.1067\/mjd.2001.110645_bib9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJM198702053160603","article-title":"Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy","volume":"316","author":"Edelson","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2001.110645_bib10","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/0190-9622(90)70312-6","article-title":"Photopheresis for the treatment of cutaneous T-cell lymphoma","volume":"23","author":"Armus","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.110645_bib11","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0889-8588(18)30062-5","article-title":"Photopheresis for the treatment of cutaneous T-cell lymphoma","volume":"9","author":"Lim","year":"1995","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1067\/mjd.2001.110645_bib12","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0190-9622(96)90119-X","article-title":"Treatment of cutaneous T-cell lymphoma with extra-corporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution","volume":"35","author":"Gottlieb","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.110645_bib13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0140-6736(05)66242-3","article-title":"Extracorporeal photopheresis and interferon-?in advanced T-cell lymphoma","volume":"350","author":"Dippel","year":"1997","journal-title":"Lancet"},{"key":"10.1067\/mjd.2001.110645_bib14","series-title":"Good clinical practice for trials on medicinal products in the European Community","author":"EEC","year":"1991"},{"key":"10.1067\/mjd.2001.110645_bib15","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0733-8635(18)30169-4","article-title":"Classification of cutaneous lymphomas","volume":"12","author":"Burg","year":"1994","journal-title":"Dermatol Clin"},{"key":"10.1067\/mjd.2001.110645_bib16","first-page":"1","article-title":"Classification and staging","author":"Kerl","year":"1987"},{"key":"10.1067\/mjd.2001.110645_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000247298","article-title":"Severity scoring of atopic dermatitis: the SCORAD index. Consensus report of the European Task Force on Atopic Dermatitis","volume":"186","author":"European Task Force on Atopic Dermatitis","year":"1993","journal-title":"Dermatology"},{"issue":"Suppl 3","key":"10.1067\/mjd.2001.110645_bib18","first-page":"25","article-title":"Interdisciplinary documentation of treatment side effects in oncology: present status and perspectives","volume":"174","author":"Seegenschmiedt","year":"1998","journal-title":"Strahlenther Onkol"},{"key":"10.1067\/mjd.2001.110645_bib19","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/1097-0142(197705)39:5<1967::AID-CNCR2820390509>3.0.CO;2-2","article-title":"Adriamycin therapy in advanced mycosis fungoides","volume":"39","author":"Levi","year":"1977","journal-title":"Cancer"},{"key":"10.1067\/mjd.2001.110645_bib20","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3109\/10428199809057572","article-title":"Phase II study of mitoguazone, cyclophosphamide, doxorubicin, vincristine and prednisone for patients with diffuse histologic subtypes of non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Study (PE481)","volume":"30","author":"Wiernik","year":"1998","journal-title":"Leuk Lymphoma"},{"key":"10.1067\/mjd.2001.110645_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1200\/JCO.1998.16.1.27","article-title":"CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group","volume":"16","author":"irelli","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1067\/mjd.2001.110645_bib22","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0190-9622(96)90683-0","article-title":"Photopheresis therapy for cutaneous T-cell lymphoma","volume":"35","author":"Duvic","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.110645_bib23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-0609.1993.tb01595.x","article-title":"Interferon treatment of cutaneous T-cell lymphoma","volume":"51","author":"Ross","year":"1993","journal-title":"Eur J Haematol"},{"key":"10.1067\/mjd.2001.110645_bib24","first-page":"337","article-title":"Interferon in the treatment of mycosis fungoides (MF)","volume":"72","author":"Vegna","year":"1990","journal-title":"Haematologica"},{"key":"10.1067\/mjd.2001.110645_bib25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0190-9622(93)70149-N","article-title":"Correlation of clinical responses with immunologic and morphologic characteristics in patients with cutaneous T-cell lymphoma treated with interferon ?-2a","volume":"29","author":"Springer","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.110645_bib26","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0190-9622(96)90118-8","article-title":"Long-term follow-up of patients with cutaneous T-cell lymphoma treated with extracorporeal photochemotherapy","volume":"35","author":"Zic","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.110645_bib27","first-page":"3578","article-title":"Prospective randomized multicenter clinical trial on the use of interferon ?-2a plus acitretin versus interferon ?-2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II","volume":"92","author":"Stadler","year":"1998","journal-title":"Blood"},{"key":"10.1067\/mjd.2001.110645_bib28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1200\/JCO.1995.13.1.257","article-title":"Effectiveness of interferon alfa-2a combined with phototherapy for mycosis fungoides and the S?zary syndrome","volume":"13","author":"Kuzel","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1067\/mjd.2001.110645_bib29","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/(SICI)1097-0215(19980925)78:1<70::AID-IJC12>3.0.CO;2-9","article-title":"Photoactivated 8-methoxyp-soralen treatment causes a peptide-dependent increase in antigen display by transformed lymphocytes","volume":"78","author":"Hanlon","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1067\/mjd.2001.110645_bib30","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/jca.2920100309","article-title":"T-cell responses in photoimmune therapy","volume":"10","author":"Heald","year":"1995","journal-title":"J Clin Apheresis"},{"key":"10.1067\/mjd.2001.110645_bib31","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000017926","article-title":"Extracorporeal photopheresis of cutaneous T-cell lymphoma is associated with reduction of peripheral CD4+ T lymphocytes","volume":"196","author":"Zouboulis","year":"1998","journal-title":"Dermatology"},{"key":"10.1067\/mjd.2001.110645_bib32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1751-1097.1997.tb01895.x","article-title":"Extracorporeal photochemotherapy (photopheresis) induces apoptosis in lymphocytes: a possible mechanism of action of PUVA therapy","volume":"65","author":"Enomoto","year":"1997","journal-title":"Photochem Photobiol"},{"key":"10.1067\/mjd.2001.110645_bib33","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2133.1997.tb03785.x","article-title":"Extracorporeal photochemotherapy induces apoptosis of infiltrating lymphoid cells in patients with mycosis fungoides in early stages: a quantitative histological study","volume":"137","author":"Miracco","year":"1997","journal-title":"Br J Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096220184634X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096220184634X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,15]],"date-time":"2019-12-15T21:43:25Z","timestamp":1576446205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096220184634X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,2]]}},"alternative-id":["S019096220184634X"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2001.110645","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2001,2]]}}}